Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CYP2C18 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | MYO1G | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | FUT2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | GRINA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | HBB | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | MSH5 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
mRNA | STX11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | ILK | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
mRNA | TUFM | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | ANTXRL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |